glp 1 wonder drug GLP-1s: Miracle or missed opportunity? Dr. Stephanie's GLP-Wonder, a GLP-1

10.1016/j.dsx.2018.08.012 51

Dual agonists for GLP-1/GIP or GLP-1/GCG receptors, and triple agonists for GLP-1/GIP/GCG receptors have been developed to enhance weight reduction and metabolic outcomes [15]

1 As the incidence of HF increases with age, the expected doubling in the number of people in the US aged 65 and older over the next decade will only exacerbate this burden

10.1056/NEJMoa1616011 [DOI] [PubMed] [Google Scholar] 95

Imagine if you were a big drug company with shareholders, profits to lose, etc., and you just spent ~$1 billion and ~10 years to bring a drug to market

While they share a common mechanism of action, enhancing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying, there are notable differences in their efficacy and usage in weight management